Clinical Trials Cervical Cancer Study

Protocol Title:

ACRIN 6671/GOG 0233: Utility of Pre-Operative PET/CT and USPIO MRI Prior to Primary Chemoradiation Therapy to Detect Retroperitoneal Lymph Node Metastasis in Patients with Loco-regionally Advanced (IB2, IIA=$ CM, IIB-IVA) Carcinoma of the Cervix.

Working Title:

Use of Pre-Operative PET/CT and USPIO MRI to Detect Abdominal Lymph Node Metastasis in Patients with Advanced Carcinoma of the Cervix.

Summary:

This is a multicenter clinical trial to define the utility of pre-operative Combidex (iron-based contrast) MRI scanning and FDG-PET/CT scanning prior to chemoradiation to detect retroperitoneal (abdominal) lymph node metastasis in patients with locoregionally advanced cancer of the cervix.

Enrollment Status:

Pending IRB approval.

Principal Investigator:

Rola Saouaf, MD

IRB Approval Number:

Pending

Medical Specialty Area:

Magnetic Resonance Imaging, PET/CT Imaging, Gynecologic Oncology

Condition/Disease:

Cancer of the cervix

IRB Approval Expiration Date:

Pending

Contact Information for patients wishing more information:

Name: Rene Siegel, Program Coordinator, Imaging Research
Phone: (310) 423-3398
E-mail: SiegelR@cshs.org